World of DTC Marketing

DECEMBER 2, 2021

Ad recall is essential for CPGs, but for prescription drugs, the question that’s missing is “what action did it lead to? Virtually nobody will run to their doctor to ask about a drug they saw on TV without doing research first. ” Uh…no. The post A scientific approach to irrational consumer choices.

Food and Drug Administration 185

Food and Drug Administration Side effects FDA Prescription 185

World of DTC Marketing

MAY 13, 2021

One study analyzed the drug ads of an anti-hypertensive drug in 210 issues of the NEJM between 1985 to 1996 and showed increased ad frequency was associated with an increase in prescriptions. Manhatten Research Taking The Pulse 2017. 2017 study. But there are also warnings. But what about online? Medscape reaches over 3.6

Physicians 173

Physicians Marketing Drug Sample Pharma 173

World of DTC Marketing

JUNE 27, 2021

Yet the media has led with “diabetes drug leads to major weight loss” Will doctors inform patients? SUMMARY: According to the NEJM “in participants with overweight or obesity, 2.4 But, will physicians tell patients that results depend on lifestyle intervention and a low-calorie diet?

Side effects 194

Side effects Patients Insurance Doctors 194

pharmaphorum

SEPTEMBER 30, 2022

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year.

FDA 84

FDA Doctors Patients Prescription 84

pharmaphorum

JULY 15, 2022

Things became litigious in 2017, when a Delaware court found that Teva’s label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK’s RE40,000 patent, which was reissued by the Patent and Trademark Office (PTO) in 2008.

Prescription 52

Prescription Doctors Government Marketing 52

PM360

OCTOBER 22, 2024

They become supportive extensions of the brand that work on a personalized level with patients and care teams, from the moment the prescription is written to other important points along the treatment journey. Even straightforward interactions like the initial prescription can be cluttered with unnecessary overlap and misalignment.

Patients 59

Patients Healthcare Provider Pharma Prescription 59

PM360

AUGUST 29, 2022

Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. Xyzal —which launched in 1995 but entered the OTC market in 2017—found success with a creative that debuted in February. Affordability is key for Rx advertisers.

Pharma 98

Pharma Prescription Marketing Pharmaceutical Sales 98